from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1598c/-

LFCtreatmentdescriptionclass of inhibitor

0.832

Amikacinug/mL Amikacintranslation

1.183

Cap5-10ug/mL Capreomycintranslation

1.023

Rox10-50 ug/mL Roxithromycintranslation

-0.501

SM2-5 ug/mL Streptomycintranslation

1.689

Tet5-10 ug/mL Tetracyclinetranslation

0.288

Rif0.2-5ug/mL Rifampicintranscription

-0.126

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.156

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.351

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.605

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.435

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.357

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.308

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.447

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.220

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.191

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.416

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.638

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.703

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.678

KCN5-20 ug/mL Potassium cyaniderespiration

-1.306

NaN30.2-2 mM Sodium aziderespiration

-0.491

Nigericin50 uM Nigericinrespiration

-0.167

TRC10-150 ug/mL Triclosanrespiration

1.129

TRZ10-25 ug/mL Thioridazinerespiration

1.463

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.307

menadione6-10 ug/mL Menadionerespiration

-0.029

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.487

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.459

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.432

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.996

NRP_1Non-replicating persistence stage 1dosRassociated

-0.204

Amp0.2mg/mL AmpicillincellWall

0.255

Cephalexin20-100 ug/mL CephalexincellWall

-0.498

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.861

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.681

EMB10-20 ug/mL EthambutolcellWall

0.159

Eta12-40 ug/mL EthionamidecellWall

0.452

INH0.2-0.4 ug/mL IsoniazidcellWall

0.035

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.033

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.242

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.148

BZA0.12 mg/mL BenzamidearomaticAmides

-0.553

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.159

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.685

H2O24 mM hydrogen peroxideDNAdamaging

0.127

Levo10 ug/mL LevofloxacinDNAdamaging

-0.513

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.626

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.122

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.863

UVUV-irradiationDNAdamaging

1.173

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.473

Antimycin12.5-50 ug/mL Antimycin A?

-0.138

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.040

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.835

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.571

PA8240.2-2 ug/mL PA-824?

0.139

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.169

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.051

Verapamil50 uM Verapamil?

0.123

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.193

methoxatin10-20 ug/mL Methoxatin?